Hematopoietic Stem Cell Transplantation
170
30
35
78
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
14 trials with published results (8%)
Research Maturity
78 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.8%
3 terminated out of 170 trials
96.3%
+9.8% vs benchmark
11%
19 trials in Phase 3/4
18%
14 of 78 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 78 completed trials
Clinical Trials (170)
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients
Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
Physical Fitness of Allogeneic Stem Cell Transplant
Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Art and Physical Therapy in Pediatric HCT
A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors